Among them, more immune cell infiltration, especially the density and localization of CD8+ T cells in the tumor immune microenvironment (TIME) has been demonstrated to be correlated with a favorable response to ICBs in various cancer types (14, 15). The gene discussed is CD8A; the disease is neoplasm.